Paul Carleton is listed as a director and promoter on 9 SEC Form D filings by 2 issuers between Jul 2009 and Mar 2020: CLINICAL OUTCOMES MANAGEMENT SYSTEMS LLC (Broadview Heights, OH — other technology — 2009–2015; $4.9M reported sold to 32 investors) and Breuer Premium Pet Food Company, Inc. (Bedford Hills, NY — industry reported as "Other" — 2018–2020; $1.63M reported sold to 12 investors).
What this means 2 separate companies raised money with this person listed as director and promoter, over about 11 years. Across those companies the filings report $6.53M sold in total.
1 of the issuers belongs to the sponsor group Breuer Premium Pet Food (2 issuers, $1.05M reported sold, 2017–2020).
What this means A sponsor group is one team that sets up a new company for each deal. Breuer Premium Pet Food has 2 companies on file and $1.05M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 bankruptcy cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 9 public filings for Paul Carleton and found 12 differences: Form D filed 51 days after the first sale; Paul Carleton's role changed at CLINICAL OUTCOMES MANAGEMENT SYSTEMS LLC: director, promoter → director; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.